Pharmacy Practice
Affordable Medicines
Biosimilars
Compliance
Compounding
Drug Approvals
Geriatrics
Hospital/Health System
In-Pharmacy Vaccines
Law
Medication Management
News & Trends
OTC
Pharmacist Resources
Pharmacy Technician
Pharmacy Week
Specialty Pharmacy
Technology
Disease State
Allergy
Autoimmune
Breast Cancer
Cardiovascular
Cold & Flu
COPD
COVID-19
Dermatology
Diabetes
Epilepsy
Gastroenterology
Hematology
Hepatitis
HIV/AIDS
Huntington's Disease
Infectious Disease
Infusion
Lung Cancer
Mental Health
mRNA Technology
Neurology
Oncology
Ophthalmology
Orthopedics
Pain Management
Pediatrics
Respiratory
Rheumatoid Arthritis
RSV
Schizophrenia
Shingles
Transplant
Urology/Nephrology
Women’s Health
Health Awareness Month
Videos
Patient Teaching Aid
Publications
Featured Issue
Featured Supplements
Conference Coverage
Continuing Education
Subscribe
GENERIC MEDICATIONS
December 20, 2019
Record Number of Generics Approved in 2019
December 20, 2019
Generic and Brand Hypothyroid Meds Equally Effective for CVD
November 14, 2019
Ranitidine Recalls Continue for NDMA Contamination
November 14, 2019
Insulin Manufacturers Authorize Half-Price Generics
May 18, 2018
Navigating the Generic Regulatory Landscape
June 16, 2017
Getting a Handle on Generic-Drug Prices
June 23, 2015
Endo Acquires Par Pharmaceutical to Expand Generics
October 16, 2014
Purple Book Introduced for Biosimilars
May 21, 2013
FDA Blocks Generic Versions of Original OxyContin
January 23, 2013
Generic Drugs’ Safety Labeling Often Incorrect
November 20, 2012
Court Instructs FDA to Approve Watson’s Generic Actos
November 14, 2012
Par to Acquire 14 Generics
September 19, 2012
GPhA Receives Favorable Opinion on Shortage Initiative
Load More
X
October 2024
In This Issue
Archives
Subscription
×
Full Image